SPECIAL REPORT: Update on the Johnson & Johnson COVID-19 Vaccine and Blood Clot Risk
Episode 13 min 32s

SPECIAL REPORT: Update on the Johnson & Johnson COVID-19 Vaccine and Blood Clot Risk

Dr. Derek Stitt speaks with FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks about cases of thrombosis after the Johnson & Johnson COVID-19 vaccine, potential risk factors, and suggestions for patient care.

You May Also Like

Community discussion